Pharmaceutical Technology
August 01, 2017
Features
2017 Supplement
3
CMOs must embrace flexibility in their technology decisions and business arrangements.
August 01, 2017
Features
2017 Supplement
3
Research suggests that on-site audits are becoming less meaningful because suppliers are less willing to devote time to them.
August 01, 2017
Features
2017 Supplement
3
Requirements for early- and late-stage trial manufacturing may differ, but complying with good practices, maintaining blind studies, and considering logistics remain crucial at all times.
August 01, 2017
Features
2017 Supplement
3
Eric Jayjock, Patheon’s director of continuous manufacturing, discusses the CDMO’s plans for its new continuous manufacturing business.
August 01, 2017
Features
2017 Supplement
3
Successful development requires coordinating and aligning drug and device design, focusing on a complete drug delivery system that meets patients’ needs.
August 01, 2017
Features
2017 Supplement
3
TraceLink’s Graham Clark, director of contract supplier relationships and cofounder, and Brian Daleiden, vice-president of industry marketing, shared insights into industry’s serialization readiness as well as recent trends and developments with Pharmaceutical Technology.
August 01, 2017
Features
2017 Supplement
3
Advanced digital ledger technologies offer potential solutions, but are still several years away from practical use.
August 01, 2017
Features
2017 Supplement
3
The contract development and manufacturing organization (CDMO) Aesica Pharmaceuticals has had a serialization program in place for the past five years, and recently installed capabilities for serialization at all its packaging facilities.
August 01, 2017
Features
2017 Supplement
3
Elevating the project management function can improve transparency and enable companies to react faster to internal and external change.
August 01, 2017
Issue PDF
2017 Supplement
3
Click the title above to open the Pharmaceutical Technology 2017 Outsourcing Resources Supplement in an interactive PDF format.